Agarwal told CNBC-TV18, "Lupin is a strong stock in pharma sector. Not only hold but I would suggest a buy on this stock for new investors as well. They have reported strong set of numbers; profit after tax was up by around 43 percent. Not only domestic market the entire US, Japan and South African market has grown well."
"The management is looking at improving margins from 20 percent current to 23 percent by this year. The company is on a strong footing and with the new approvals the next year is also going to be very good. We have a target of at least 20-25 percent return in the stock in the next six-nine months. So I would suggest a hold and a buy on dips," Agarwal added.
Anda sedang membaca artikel tentang
Lupin to jump 25% in next 6-9 months, says Agarwal
Dengan url
https://untukkesehatanda.blogspot.com/2013/02/lupin-to-jump-25-in-next-6-9-months.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Lupin to jump 25% in next 6-9 months, says Agarwal
namun jangan lupa untuk meletakkan link
Lupin to jump 25% in next 6-9 months, says Agarwal
sebagai sumbernya
0 komentar:
Posting Komentar